AVEO PHARMACEUTICALS, INC. - FORM 10-Q - EX-32.2 - CERTIFICATION OF PFO PURSUANT TO SECTION 906 - August 9, 2011

Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - AVEO PHARMACEUTICALS, INC.Financial_Report.xls
10-Q - FORM 10-Q - AVEO PHARMACEUTICALS, INC.d10q.htm
EX-10.3 - REGISTRATION RIGHTS AGREEMENT - AVEO PHARMACEUTICALS, INC.dex103.htm
EX-31.2 - CERTIFICATION OF PFO PURSUANT TO SECTION 302 - AVEO PHARMACEUTICALS, INC.dex312.htm
EX-32.1 - CERTIFICATION OF PEO PURSUANT TO SECTION 906 - AVEO PHARMACEUTICALS, INC.dex321.htm
EX-10.1 - RESEARCH AND LICENSE AGREEMENT - AVEO PHARMACEUTICALS, INC.dex101.htm
EX-31.1 - CERTIFICATION OF PEO PURSUANT TO SECTION 302 - AVEO PHARMACEUTICALS, INC.dex311.htm
EX-10.2 - COMMOM STOCK PURCHASE AGREEMENT - AVEO PHARMACEUTICALS, INC.dex102.htm

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of AVEO Pharmaceuticals, Inc. (the “Company”) for the fiscal quarter ended June 30, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, David B. Johnston, Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that, to his knowledge on the date hereof:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 9, 2011

 

/s/ David B. Johnston

David B. Johnston
Chief Financial Officer

AVEO PHARMACEUTICALS, INC. Reports